Ergoteles LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 83 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$416,000
+26.4%
403,508
-16.4%
0.02%
+50.0%
Q2 2022$329,000
-39.6%
482,900
+342.0%
0.01%
-41.2%
Q1 2021$545,000109,2570.02%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 664,477$890,0000.05%
ARDSLEY ADVISORY PARTNERS LP 50,000$67,0000.01%
MYCIO WEALTH PARTNERS, LLC 30,500$41,0000.00%
Procyon Advisors, LLC 2,500$3,0000.00%
WealthPLAN Partners, LLC 20,000$16,0000.00%
Renaissance Technologies 1,118,623$1,499,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 308,794$412,0000.00%
BlackRock Inc. 404,056$541,0000.00%
TWO SIGMA SECURITIES, LLC 13,544$18,0000.00%
JPMORGAN CHASE & CO 16$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders